Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
75 participants
OBSERVATIONAL
2021-06-01
2021-12-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The investigators want to find out whether changes in everyday speech can signal the worsening of asthma.
The investigators are planning to collect voice samples from people as their asthma gets better and worse in order to analyse the changes in voice quality - if any.
The participants donating the voice samples will remain anonymous and the voice files will be transferred securely to our analytic system.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Voice Analysis in Asthmatic Patients With Machine Learning Models
NCT06820671
Real-time Remote Asthma Monitoring Through Smartphone Voice Analysis
NCT05850390
Assessing Decision Maker Tools for Asthma: the Asthma APGAR
NCT01446315
Biomarkers in Exhaled Breath From Asthmatic Patients
NCT00635271
Personalized Mobile Phone Video Recording to Improve Inhaler Techniques in Asthma Patients.
NCT04503837
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Those interested in participating will be shown a short plain English description of the goals and methodology of the project before enrolled.
A maximum of 9 voice sample recording session will be carried out on the phones of participants and take less than 2 minutes each, so participants will spend a total of fewer than 18 minutes during the entire trial.
Sessions will be offered after participants have recorded their asthma symptoms, lung function and inhaler use in the normal course of using the app. Participants may accept or decline each individual offer to record their voice.
Participants will have a chance to play each voice recording before sharing it anonymously with the investigators. Participants can discontinue their participation at any time and can ask investigators to delete all their data.
The investigators will be analyse collected voice samples for changes in voice quality. The changes in voice quality will be compared against changes in lung function and asthma symptoms to determine what changes in voice quality, if any, are indicative of a change in asthma control.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Participants
Current user of the Smart Asthma app
Recording voice samples
A maximum of 9 voice sample recording session will be carried out on their phones and take less than 2 minutes each
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Recording voice samples
A maximum of 9 voice sample recording session will be carried out on their phones and take less than 2 minutes each
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Over 18
* Volunteers to participate
* Agrees to terms
Exclusion Criteria
18 Years
99 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Thomas Antalffy
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Thomas Antalffy
Managing Director
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Thomas Antalffy, MD
Role: PRINCIPAL_INVESTIGATOR
Managing Director
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
VoiceRecPilot
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.